Precision Medicine Group: just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Precision Medicine Group: , plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Precision Medicine Group Secures Major Investment from Blackstone
Description
Precision Medicine Group (PMG) and Blackstone (NYSE: BX) today announced that PMG, a leading next-generation provider of drug development and commercialization services, has completed a major investment and recapitalization led by funds managed by Blackstone (“Blackstone”). The investment includes significant participation from Precision’s co-founders, Ethan Leder and Mark Clein, as well as current shareholders Berkshire Partners, TPG Growth, Oak HC/FT, and Vida Ventures.
Related People
Watching Precision Medicine Group: ? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan